Prot# IMCL CP15-1008: A Phase 2 Study of a Human Anti-PDGFR Monoclonal Antibody (IMC-3G3) in Previously Treated Patients with Unresectable and/or Metastatic Gastrointestinal Stromal Tumors (GIST)

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/27/11 → 12/27/17

Funding

  • ICON Clinical Research, LLC (IMCL CP15-1008 // IMCL CP15-1008)
  • ImClone Systems Incorporated (IMCL CP15-1008 // IMCL CP15-1008)